Language: English
Physician profile
Dr. med. Sivagurunathan Sutharsan
Physician · Department of Pulmonary Medicine
Consultant, Department of Pulmonary Medicine, Cystic Fibrosis Centre · Ruhrlandklinik Essen
This profile summarises the career and qualifications of Dr. med. Sivagurunathan Sutharsan factually and with sources. The choice of physician and clinic always rests with the patient.
Profile summary and areas of expertise
Sivagurunathan Sutharsan is a consultant in the Department of Pulmonary Medicine at Ruhrlandklinik in Essen and a member of the medical team of the Cystic Fibrosis Centre for Adults. Sivagurunathan Sutharsan holds clinics in the central outpatient department for patients with bronchiectasis and cystic fibrosis. The publications of Sivagurunathan Sutharsan focus mainly on clinical trials in cystic fibrosis, on bronchiectasis and on primary ciliary dyskinesia.
- Cystic fibrosis (mucoviscidosis) in adulthood
- Bronchiectasis
- Clinical trials in rare lung diseases
Clinical work and institutions
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen (MedVici profile of the institution)
Klinik für Pneumologie
- currentConsultant, medical team of the Cystic Fibrosis Centre for Adults
- from 2009Clinical work, Department of Pulmonary Medicine (self-reported)
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen (MedVici profile of the institution)
Zentralambulanz
- currentClinics for bronchiectasis and cystic fibrosis
Qualifications and training
- 2018Doctorate (Dr. med.), University of Duisburg-Essen
Publications, talks and media
Documented contributions directly related to Dr. med. Sivagurunathan Sutharsan, grouped by type and listed newest first within each type. Every title links to the original source.
Specialist publications according to the author affiliation – no statement about treatment success or the quality of the institution. MedVici Health currently does not show cancer-related publications.
Doctoral thesis (1)
- Behandlung der obstruktiven Schlafapnoe mit justierbarer Unterkieferprotrusionsschiene Typ NARVAL: Untersuchung von Effektivität, Adhärenz, Schlafqualität und Nebenwirkungen (original source, opens in a new window)
Dissertation, Universität Duisburg-Essen (Deutsche Nationalbibliothek)
Scientific publications (11)
- Interferon-γ-response to mycobacterial glycopeptidolipids in patients with pulmonary non-tuberculous mycobacterial infection (original source, opens in a new window)
Medical Microbiology and Immunology (PubMed 42776260)
- KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of MUC1 Genotype (original source, opens in a new window)
Journal of Clinical Medicine (PubMed 42355723)
- Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC (original source, opens in a new window)
ERJ Open Research (PubMed 39286058)
- Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert's syndrome (original source, opens in a new window)
BMC Pulmonary Medicine (PubMed 38956524)
- Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry (original source, opens in a new window)
The Lancet Regional Health – Europe (PubMed 37554663)
- Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis (original source, opens in a new window)
BMC Pulmonary Medicine (PubMed 36437445)
- Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial (original source, opens in a new window)
The Lancet Respiratory Medicine (PubMed 34942085)
Contact via MedVici
Questions about this profile and about MedVici Health's services for patients are answered by MedVici Health. Please do not send medical reports or other health data by email — there is an encrypted channel for documents.
Disclosure: Ruhrlandklinik is listed on MedVici Health with a clinic profile. Its managing director, Jürgen Schlebrowski, is a member of the MedVici Health Board of Advisors.
Reference profile based on publicly available information. No business relationship with MedVici Health is implied or claimed.
MedVici Health does not refer patients to specific physicians; patients choose their physician and clinic themselves.
Professional details based on publicly available information from the institution and bibliographic records, as of 19.10.2026.